Admin Access

Enter your blog admin password to continue.

Incorrect password. Try again.

Blog Admin — Sheemaz Raza

Write a New Post

Posts go live immediately on your public website. No HTML editing required.

Published Posts

Regulatory excellence isn't just about compliance — it's about building the trust that gets life-changing therapies to patients faster.
Sheemaz signature

Regulatory Affairs Expert — MEA & GCC

17+ years leading regulatory strategy across pharmaceuticals, medical devices, and cosmetics in the UAE, GCC, Levant, Egypt, and Iraq. I hold established health authority relationships and a proven track record of fastest-in-class approvals.

EDE Licensed Pharmacist EDE/MOHAP · SFDA · MOH-Kuwait Biological/Pharma Medical Devices Cosmetics Dubai, UAE
Get in Touch → LinkedIn ↗
Sheemaz Raza — Senior Regulatory Affairs Manager
EDE Licensed Pharmacist · Dubai
Measurable outcomes
Regulatory leadership that moves business.

Every regulatory strategy I lead is tied to a commercial outcome — faster launches, market access wins, and compliance infrastructure that scales.

12+
Markets with integrated Regulatory QMS frameworks
300+
Product renewals managed across UAE at Julphar
89%
Performance target matrix achieved at Actavis / Allergan
3
Regulatory barriers overcome through strategic alternate pathways

Regulatory Submission Pathway Optimization

Developed optimized regulatory engagement protocols for complex biological drug submissions, navigating parallel authority requirements through strategic dossier management and authority relationship building. Established replicable frameworks for efficient submission processing.

⬆ Streamlined submission processes and authority engagement

Multi-Authority Registration Strategy for Consumer Goods

Identified regulatory barriers preventing market entry for consumer goods portfolio. Developed alternate registration pathway proposing harmonized submission strategy across multiple UAE authorities, enabling product launch without full re-registration. Coordinated regulatory positioning and authority stakeholder management.

✔ Market entry enabled through strategic pathways

Cross-Functional Compliance Infrastructure

Led implementation of an innovative HCP compliance software platform, resolving cross-functional process gaps and creating a scalable governance framework across commercial, medical, and legal teams.

✔ 100% compliance programme launched

Multi-Category Portfolio Leadership

Simultaneously led regulatory strategy across biologicals, pharmaceuticals, medical devices, and cosmetics — a rare cross-category competency that enables commercial teams to move faster with a single regulatory partner.

✔ Biological/Pharma · Medical Devices · Cosmetics

Regulatory QMS & Governance

Built end-to-end Regulatory QMS frameworks including SOPs, audit programs, and compliance workflows operating across 12+ markets — creating the internal infrastructure for scalable market expansion.

✔ QMS covering 12+ markets

Geo-Expansion Submissions

Supported regulatory submissions for geo-expansion into emerging markets, identifying early-mover opportunities and building the dossier infrastructure for new market entry in complex frontier markets.

⬆ New markets unlocked through strategic pathways
Deep dives
Case studies in regulatory excellence

Real challenges, real strategies, real outcomes — across pharmaceutical, medical device, and market access categories.

These case studies illustrate regulatory problem-solving approaches and market access strategies based on real-world scenarios. They are educational examples and do not constitute professional advice. Each regulatory situation is unique and context-dependent. For specific regulatory challenges affecting your organization, consult with qualified regulatory professionals.

Regulatory Strategy · UAE · MOHAP / EDE

Strategic Regulatory Pathway Optimization

MarketUAE
CategoryBiological Drug
AuthorityMOHAP / EDE

Complex biological drug submissions require navigating parallel authority requirements, technical dossier complexity, and evolving regulatory expectations. Standard submission timelines often extend due to iterative authority engagement and technical clarifications.

I developed and executed an optimized regulatory submission strategy — restructuring the technical dossier to align with MOHAP/EDE latest requirements, establishing parallel authority engagement protocols, and building a replicable framework for authority dialogue and submission management.

Result: Established authority engagement framework and submission optimization protocols that reduced standard processing timelines and created replicable infrastructure for future complex submissions.
Market Access · Consumer Goods · Multi-Authority Strategy

Multi-Authority Registration Pathway for Consumer Goods

ChallengeMarket Entry Barriers
CategoryConsumer Goods
ScopeMulti-Authority (UAE)

A consumer goods portfolio faced significant regulatory barriers to market entry in UAE, with standard registration requirements presenting timelines and cost constraints that threatened commercial viability. Traditional pathways appeared blocked due to evolving authority requirements and classification uncertainties.

I conducted a comprehensive regulatory landscape analysis, identifying a previously unconsidered alternate registration pathway that leveraged harmonized submission strategies across multiple UAE authorities. I developed the regulatory positioning, coordinated stakeholder engagement across authorities, and built the dossier infrastructure for the alternate approach.

Result: Identified and enabled alternate market entry pathway, allowing product launch without full re-registration. Established replicable multi-authority coordination framework for future portfolio expansion.
HCP Compliance · Cross-functional · Software Implementation

HCP Compliance Platform — From Gap to Governance

ScopeRegional
CategoryCompliance Tech
TeamsCommercial, Medical, Legal

Escalating HCP interaction volumes exposed gaps in documentation, approval workflows, and compliance tracking — creating regulatory and reputational risk across the region's commercial operations.

I led the evaluation, selection, and implementation of a dedicated HCP compliance software platform, building the governance framework, SOP architecture, and cross-functional change management process from the ground up.

Result: Full compliance programme live across regional teams, resolving audit risks and creating a scalable infrastructure for HCP engagement management.
Market Entry · Iraq · Lebanon · Geo-expansion

Regulatory Pathways for Frontier Market Entry

MarketsIraq, Lebanon
CategoryPharma / Med Devices
CompanyActavis / Allergan

Iraq and Lebanon presented significant regulatory complexity for product expansion — underdeveloped formal submission pathways, unpredictable authority timelines, and limited available guidance for multinationals.

I mapped the available regulatory entry routes for each market, designed dossier structures adapted to local requirements, and built the submission infrastructure that enabled the commercial team to activate both markets.

Result: Successful geo-expansion regulatory submissions delivered for both markets, unlocking new revenue streams ahead of competitor entry.
Regional depth
GCC & MEA market expertise

Direct relationships with health authorities across 12+ markets — not just knowledge, but established working relationships built over 17+ years.

🇦🇪
United Arab Emirates
MOHAP · EDE · Dubai Health Authority
Primary Market
🇸🇦
Saudi Arabia
SFDA (Saudi Food & Drug Authority)
Active
🇶🇦
Qatar
Ministry of Public Health (MOPH)
Active
🇰🇼
Kuwait
Kuwait Drug & Food Control
Active
🇧🇭
Bahrain
National Health Regulatory Authority
Active
🇴🇲
Oman
Ministry of Health Oman
Active
🇯🇴
Jordan
Jordan Food & Drug Administration
Levant
🇱🇧
Lebanon
Ministry of Public Health Lebanon
Levant
🇪🇬
Egypt
Egyptian Drug Authority (EDA)
Active
🇮🇶
Iraq
Iraqi Ministry of Health
Frontier

Core Regulatory Competencies

eCTD / CTD Submissions Variation Management Post-Market Surveillance CAPA Management Labeling & Artwork Promotional Compliance Lifecycle Management Regulatory Intelligence Risk Management Health Authority Engagement Regulatory QMS SOP Development IMDRF Frameworks ISO 13485

Product Categories

Pharmaceuticals Biologics Medical Devices Cosmetics OTC Products Injectable Therapeutic Agents Dermatology

Credentials & Affiliations

UAE Golden Visa EDE Pharmacist-in-Charge B.Pharm — Mumbai University WHO CTD Training HCP Compliance — Seton Hall GDP & Storage Certified RAPS Member Veeva Vault PromoMats eDMS Veeva Vault Medcoms COMPLY RIMS
Professional journey
17+ years of regulatory excellence
Galderma · 2016–Present Actavis / Allergan · 2014–2016 Julphar · 2009–2013
April 2016 — Present · 10+ Years
Regulatory Affairs Manager, MEA-GCC
Galderma Middle East FZ LLC · Dubai, UAE
Lead all regional Regulatory Affairs operations across pharmaceuticals, medical devices, and cosmetics for UAE, GCC, Levant, Egypt, and Iraq. Define and execute regulatory strategies aligned with commercial launch timelines and portfolio value. Partner with Commercial, Market Access, Quality, Supply Chain, and Legal teams.
  • Optimized regulatory submission pathways and authority engagement protocols with MOHAP/EDE, establishing replicable frameworks for complex submissions
  • Led cross-functional regulatory portfolio optimization strategy with Commercial, Medical, and Legal teams
  • Designed and implemented HCP compliance software platform across regional teams, establishing governance framework and SOPs
  • Built and governed Regulatory QMS frameworks covering 12+ markets, including audit programs and lifecycle management
  • Served on selection committee for Veeva Vault PromoMats implementation, contributing to commercial operations efficiency
  • EDE-licensed Pharmacist-in-Charge — Scientific Office
January 2014 — February 2016 · 2 Years
Regulatory Affairs Associate
Actavis / Allergan · Dubai, UAE
Supported regulatory submissions and lifecycle management activities across Middle East markets. Contributed to geo-expansion regulatory projects for emerging markets.
  • Led geo-expansion regulatory submissions for Iraq and Lebanon
  • Supported lifecycle management across Middle East portfolio
  • Achieved 89% performance target matrix
July 2009 — December 2013 · 4.5 Years
Regulatory Affairs Officer
Gulf Pharmaceutical Industries (Julphar) · Ras Al Khaimah, UAE
Managed end-to-end renewals for over 300 OTC, pharmaceutical, and medical device products in the UAE. Supported third-party and local manufacturing regulatory projects.
  • Managed renewals for 300+ products across OTC, pharma, and medical devices
  • Supported third-party and local manufacturing regulatory activities
  • Built foundational expertise in MOHAP submission requirements
Regulatory insights
Perspectives on GCC regulation

These perspectives represent my professional observations on regulatory affairs, market trends, and industry practices in the GCC and MEA region. Views shared are my own and do not constitute professional regulatory advice, company policy, or guidance for specific submissions. For regulatory matters affecting your organization, consult with qualified regulatory professionals.

The One Question That Separates Good RA Leaders from Great Ones
#RegulatoryAffairs#Leadership#CareerDevelopment#PharmaLeaders#Dubai#StrategicThinking#GCC

The One Question That Separates Good RA Leaders from Great Ones

Regulatory Strategy and how it makes a big difference

22 April 2026
The Importance of Simplifying Regulatory Processes in the Middle East
#Process Simplification#Middle East#Regulatory Affairs#GCC

The Importance of Simplifying Regulatory Processes in the Middle East

How simplified regulatory processes drive faster, more effective outcomes across Middle East markets

26 January 2026
Looking Back: What I Believed Early in My RA Journey — And What Still Holds True
#Regulatory Affairs#Career Reflection#Patient Safety#UAE#Growth Mindset

Looking Back: What I Believed Early in My RA Journey — And What Still Holds True

Reflections from my earlier career as a Regulatory Affairs Professional — the values and convictions that still guide my work today

10 May 2025
Navigating the Regulatory Affairs Environment in the Middle East: Opportunities and Challenges
#Middle East#Regulatory Affairs#GCC#UAE#Saudi Arabia#Market Access#Life Sciences#Pharma

Navigating the Regulatory Affairs Environment in the Middle East: Opportunities and Challenges

Key trends, challenges, and opportunities in the Middle East's regulatory landscape across Saudi Arabia, UAE, Egypt, and the GCC

12 October 2024
New FDA MedWatch Alert: Iodine-containing Contrast Agents and Thyroid Risk in Infants
#FDA#Drug Safety#Medical Imaging#Regulatory Alert#Pharmacovigilance

New FDA MedWatch Alert: Iodine-containing Contrast Agents and Thyroid Risk in Infants

FDA Drug Safety Communication on rare cases of underactive thyroid in infants following iodine-containing contrast agents used in medical imaging

18 November 2015
Professional network
Get in touch

I'm always open to meaningful conversations with peers, collaborators, and industry leaders across the GCC and MEA regulatory space. Feel free to reach out.

Email
[email protected]
LinkedIn
linkedin.com/in/sheemaz-raza
Location
Dubai, UAE